NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
1.230
-0.160 (-11.51%)
Mar 9, 2026, 3:50 PM EDT - Market open
NovaBay Pharmaceuticals Employees
As of December 31, 2024, NovaBay Pharmaceuticals had 14 total employees, including 13 full-time and 1 part-time employees. The number of employees decreased by 12 or -46.15% compared to the previous year.
Employees
14
Change (1Y)
-12
Growth (1Y)
-46.15%
Revenue / Employee
$735,857
Profits / Employee
$231,643
Market Cap
32.13M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 123 |
| Atara Biotherapeutics | 38 |
| Jasper Therapeutics | 27 |
| Lisata Therapeutics | 26 |
| Actinium Pharmaceuticals | 25 |
| PDS Biotechnology | 24 |
| INmune Bio | 22 |
| Outlook Therapeutics | 17 |
NBY News
- 4 months ago - NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards - GlobeNewsWire
- 6 months ago - NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting - GlobeNewsWire
- 6 months ago - NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share - GlobeNewsWire
- 7 months ago - NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - GlobeNewsWire
- 1 year ago - NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders - Business Wire
- 1 year ago - NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal - Business Wire
- 1 year ago - NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders - Business Wire
- 1 year ago - NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting - Business Wire